VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 106 filers reported holding VENTYX BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,716,788 | +11.4% | 2,957,581 | +5.2% | 0.02% | +15.8% |
| Q2 2023 | $92,234,650 | -9.2% | 2,812,032 | -7.3% | 0.02% | -13.6% |
| Q1 2023 | $101,629,721 | -18.2% | 3,033,723 | -20.0% | 0.02% | -24.1% |
| Q4 2022 | $124,282,068 | +1.5% | 3,790,243 | +8.0% | 0.03% | +3.6% |
| Q3 2022 | $122,501,000 | +157.4% | 3,509,064 | -9.8% | 0.03% | +133.3% |
| Q2 2022 | $47,591,000 | -7.4% | 3,891,328 | -0.5% | 0.01% | +9.1% |
| Q1 2022 | $51,377,000 | -31.3% | 3,911,910 | +0.5% | 0.01% | -26.7% |
| Q4 2021 | $74,736,000 | – | 3,891,028 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |